Regulation of equine plasma products
The AVMA urges the FDA and the USDA to identify means and methods to regulate all equine plasma products intended for use in horses, with or without claims, according to the appropriate agency’s standards for animal blood product quality. These standards should be designed to ensure equine plasma products remain safe, effective, and readily available to customers and patients.
Related resource
American Association of Equine Practitioners (AAEP) white paper